Naltrexone may be the most important therapeutic breakthrough in cancer treatment with no side effects. Previous studies have shown that for 30 to 90 days comes to visible stagnation in the growth of the tumor tissue, and after 6 to 9 months tumors usually disappear, and go into a remission.
Naltrexone is a unique immune regulator that has shown remarkable results in the treatment of malignant diseases, destroying tumors by increasing the levels of endorphins in the body. Also, naltrexone has shown excellent results in the treatment of autoimmune diseases, including HIV and central nervous system disorders,
People with autoimmune diseases that started taking low dose naltrexone experienced outstanding results. Patients diagnosed with HIV, lupus, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, ALS (amyotrophic lateral sclerosis), and Chron’s disease showed remarkable improvements in the first few weeks of the treatment with naltrexone.
Naltrexone was originally approved, by the FDA in 1984 for the purpose of helping drug addicts, by blocking the brain receptors that receive narcotic substances. For this purpose, naltrexone is typically available in doses of 50 milligrams.
But more recently, it has become clear that low dose naltrexone (1,5 to 4,5 milligrams) shows positive effects on the body’s immune system and destroys cancer cells.
In the mid-1990’s, Dr. Bihari found that patients in his practice with cancer (such as lymphoma or pancreatic cancer) could benefit, in some cases dramatically, from taking naltrexone, which in small doses encourage the synthesis of endorphins in the body that destroy the cancer cells. According to Dr. Bihari, nearly a quarter of his patients had at least a 75 percent reduction in tumor size, and nearly 60 percent of his patients demonstrated disease stability.
Naltrexone has shown positive effects in the treatment of the following types of cancer
– Bladder cancer
– Liver cancer
– Colorectal cancer
– Pancreatic cancer
– Renal cell carcinoma
– Prostate cancer
– Throat cancer
– Lung cancer
– Glioblastoma, astrocytoma
– Breast cancer
– Uterine cancer
– Ovarian cancer
– Lymphomas (Hodgkin’s and Non-Hodgkin’s)
– Lymphocytic leukemia (chronic)
– Malignant melanoma
– Multiple myeloma
Naltrexone, endorphins, and cancer
Low dose naltrexone has a blocking effect on the tumor growth. It increases the levels of endorphins and beta-endorphins. All of this leads to increased number of receptors on the membranes of cancer cells, which causes apoptosis (programmed cell death) of cancer cells. Also, elevated endorphin levels increase the number and the activity of natural killer cells (Nk-cells) and CD-8 lymphocytes.
Naltrexone dosage for cancer patients
The regular doses of naltrexone are between 2 and 4,5 mg daily. But, it is the best to take 4,5 mg naltrexone every night before going to bed.
Naltrexone works in the first 4 hours of sleep and then increases the level of endorphins in the body, which remains elevated in the next 24 hours.
For best results, you should combine low dose naltrexone with alpha lipoic acid (ALA).
You can buy naltrexone capsules of 4,5 mg, but also you can buy naltrexone tablets of 50 mg. Every 50 mg tablet you can disintegrate and divide into 11 equal parts. But, you must use a scale that measure in milligrams.
What are endorphins?
Endorphins are endogenous opioid peptides that function as neurotransmitters.
Endorphins are produced by, the pituitary gland and the hypothalamus during exercise, excitement, pain, eating spicy food, and orgasm. They also have pain-relieving (analgesic) effects and increase the sense of well-being, which is also great for those patients who experience pain.
The post Naltrexone – A Miracle That Could Save you From Cancer appeared first on The Healthiest Alternative.